Renaissance Technologies’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.43M | Buy |
+43,200
| New | +$2.81M | ﹤0.01% | 1798 |
|
|
2024
Q4 | – | Sell |
-42,000
| Closed | -$3.38M | – | 3706 |
|
|
2024
Q3 | $3.38M | Sell |
42,000
-13,500
| -24% | -$1.09M | 0.01% | 1695 |
|
|
2024
Q2 | $4.59M | Buy |
+55,500
| New | +$4.88M | 0.01% | 1356 |
|
|
2024
Q1 | – | Sell |
-38,500
| Closed | -$3.29M | – | 3856 |
|
|
2023
Q4 | $3.29M | Sell |
38,500
-103,800
| -73% | -$8.97M | 0.01% | 1623 |
|
|
2023
Q3 | $12.7M | Buy |
142,300
+70,900
| +99% | +$6.33M | 0.02% | 781 |
|
|
2023
Q2 | $6.08M | Buy |
71,400
+66,200
| +1,273% | +$5.6M | 0.01% | 1316 |
|
|
2023
Q1 | $430K | Buy |
5,200
+2,000
| +63% | +$162K | ﹤0.01% | 2960 |
|
|
2022
Q4 | $252K | Buy |
+3,200
| New | +$257K | ﹤0.01% | 3311 |
|
|
2022
Q3 | – | Sell |
-40,100
| Closed | -$2.61M | – | 4170 |
|
|
2022
Q2 | $2.61M | Buy |
40,100
+18,000
| +81% | +$1.07M | ﹤0.01% | 1999 |
|
|
2022
Q1 | $1.4M | Buy |
+22,100
| New | +$1.2M | ﹤0.01% | 2495 |
|
|
2021
Q4 | – | Sell |
-129,785
| Closed | -$9.16M | – | 4026 |
|
|
2021
Q3 | $9.16M | Sell |
129,785
-470,709
| -78% | -$29.7M | 0.01% | 1084 |
|
|
2021
Q2 | $40M | Sell |
600,494
-679,600
| -53% | -$48.1M | 0.05% | 405 |
|
|
2021
Q1 | $142M | Sell |
1,280,094
-296,100
| -19% | -$36.6M | 0.18% | 110 |
|
|
2020
Q4 | $187M | Sell |
1,576,194
-357,991
| -19% | -$38.5M | 0.2% | 91 |
|
|
2020
Q3 | $169M | Sell |
1,934,185
-253,600
| -12% | -$22.2M | 0.17% | 110 |
|
|
2020
Q2 | $196M | Buy |
2,187,785
+3,400
| +0.2% | +$343K | 0.17% | 117 |
|
|
2020
Q1 | $218M | Sell |
2,184,385
-255,431
| -10% | -$27.7M | 0.21% | 102 |
|
|
2019
Q4 | $280M | Sell |
2,439,816
-187,084
| -7% | -$22.6M | 0.22% | 91 |
|
|
2019
Q3 | $331M | Buy |
2,626,900
+142,500
| +6% | +$18.1M | 0.28% | 69 |
|
|
2019
Q2 | $299M | Buy |
2,484,400
+108,700
| +5% | +$10.7M | 0.26% | 76 |
|
|
2019
Q1 | $208M | Sell |
2,375,700
-43,900
| -2% | -$3.99M | 0.19% | 118 |
|
|
2018
Q4 | $242M | Buy |
2,419,600
+163,100
| +7% | +$17.1M | 0.27% | 68 |
|
|
2018
Q3 | $259M | Buy |
2,256,500
+286,800
| +15% | +$29.7M | 0.27% | 65 |
|
|
2018
Q2 | $177M | Buy |
1,969,700
+650,200
| +49% | +$54.9M | 0.19% | 97 |
|
|
2018
Q1 | $96.5M | Buy |
1,319,500
+342,400
| +35% | +$23.5M | 0.11% | 210 |
|
|
2017
Q4 | $56.8M | Buy |
977,100
+100,893
| +12% | +$5.31M | 0.06% | 386 |
|
|
2017
Q3 | $39.3M | Sell |
876,207
-43,593
| -5% | -$1.81M | 0.05% | 537 |
|
|
2017
Q2 | $36.3M | Buy |
919,800
+101,200
| +12% | +$4.16M | 0.05% | 510 |
|
|
2017
Q1 | $33.2M | Sell |
818,600
-76,600
| -9% | -$2.99M | 0.05% | 522 |
|
|
2016
Q4 | $36M | Buy |
895,200
+11,600
| +1% | +$437K | 0.06% | 466 |
|
|
2016
Q3 | $32M | Buy |
883,600
+106,300
| +14% | +$3.65M | 0.06% | 448 |
|
|
2016
Q2 | $22.5M | Buy |
777,300
+500,100
| +180% | +$15.1M | 0.04% | 608 |
|
|
2016
Q1 | $9.7M | Buy |
277,200
+87,500
| +46% | +$2.83M | 0.02% | 1160 |
|
|
2015
Q4 | $6.12M | Sell |
189,700
-70,300
| -27% | -$2.28M | 0.01% | 1335 |
|
|
2015
Q3 | $8.4M | Buy |
260,000
+213,700
| +462% | +$8.04M | 0.02% | 1042 |
|
|
2015
Q2 | $1.92M | Sell |
46,300
-38,000
| -45% | -$1.6M | ﹤0.01% | 2087 |
|
|
2015
Q1 | $3.79M | Sell |
84,300
-16,100
| -16% | -$673K | 0.01% | 1540 |
|
|
2014
Q4 | $3.76M | Buy |
100,400
+63,700
| +174% | +$2.33M | 0.01% | 1437 |
|
|
2014
Q3 | $1.28M | Sell |
36,700
-178,100
| -83% | -$6.36M | ﹤0.01% | 1907 |
|
|
2014
Q2 | $7.58M | Sell |
214,800
-39,426
| -16% | -$1.32M | 0.02% | 1004 |
|
|
2014
Q1 | $8.29M | Buy |
254,226
+228,126
| +874% | +$8.72M | 0.02% | 973 |
|
|
2013
Q4 | $1.1M | Sell |
26,100
-211,400
| -89% | -$8.7M | ﹤0.01% | 2034 |
|
|
2013
Q3 | $9.47M | Buy |
237,500
+3,600
| +2% | +$151K | 0.02% | 828 |
|
|
2013
Q2 | $9.67M | Buy |
+233,900
| New | +$9.47M | 0.03% | 756 |
|
Other funds holding HAE
VPM
VCM
RRAM
Renaissance Technologies's HAE Position: Q1 2026 in Review
Renaissance Technologies opened a new position in Haemonetics (HAE) in Q1 2026: 43,200 shares worth $2.43M. The stake represents ﹤0.01% of the portfolio and ranks #1798 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in HAE as recently as Q3 2024.
Renaissance Technologies first reported a position in HAE in Q2 2013 and has held it in 44 quarters since. The position peaked at $331M in Q3 2019. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Renaissance Technologies held 43,200 shares of Haemonetics worth $2.43M as of Q1 2026.
- Haemonetics was a new Renaissance Technologies position in Q1 2026.
- Haemonetics made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1798 holding.
- Renaissance Technologies first reported a position in Haemonetics in Q2 2013 and has held it in 44 quarters since.
- Renaissance Technologies's Haemonetics position peaked at $331M in Q3 2019.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.